About
BIOIO develops gerotherapies based on mechanisms of action to target core aging processes, aiming to extend health-span and treat metabolic diseases such as diabetes by focusing on specific metabolic pathways.
Explore BIOIO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.